Zinc Supplementation Increases the Level of Serum Insulin-Like Growth Factor-I but Does Not Promote Growth in Infants with Nonorganic Failure to Thrive

We investigated in a randomized double-blind placebo-controlled study the effects of zinc supplementation (2 mg/kg/day) for 12 weeks on growth, serum insulin-like growth factor-I (IGF-I) and insulin-like factor binding protein-3 (IGFBP-3) on 3- to 9-month-old infants with nonorganic failure to thriv...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Hormone research 1999-01, Vol.52 (4), p.200-204
Hauptverfasser:	Hershkovitz, Eli, Printzman, Ludmilla, Segev, Yael, Levy, Jacov, Phillip, Moshe
Format:	Artikel
Sprache:	eng
Schlagworte:	Dietary Supplements Double-Blind Method Failure to Thrive - drug therapy Failure to Thrive - physiopathology Growth Humans Infant Insulin-Like Growth Factor Binding Protein 3 - blood Insulin-Like Growth Factor I - metabolism Original Paper Placebos Zinc - administration & dosage Zinc - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!